Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV-mediated long-term TBX18 expression causes cardiac fibrosis and fails to induce pacemaker activity in rodents.

The Journal of clinical investigation·2026
Same author

Why patient organizations are important to improve care for people with Lynch syndrome.

Familial cancer·2026
Same author

Artificial intelligence-enhanced wearable technology enables ventricular arrhythmia prediction.

European heart journal. Digital health·2026
Same author

Effect of a grace period on false alarm rates of smartwatch-based out-of-hospital cardiac arrest detection systems: a pilot study.

Resuscitation plus·2026
Same author

<i>Zeb2os</i> Hinders Cardiac Healing by Suppressing ZEB2 Reactivation and Cardiomyocyte Dedifferentiation.

Circulation research·2026
Same author

Prognostic Value of Serum S100B Protein for Neurological Outcomes After Cardiac Arrest: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jul 19, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

Gene therapy to create biological pacemakers.

Gerard J J Boink1, Jurgen Seppen, Jacques M T de Bakker

  • 1Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Medical & Biological Engineering & Computing
|October 19, 2006
PubMed
Summary

Gene therapy offers a promising alternative to electronic pacemakers for treating disrupted sinus node function. Research explores various gene therapy strategies, including stem cells and bioengineered ion channels, to create biological pacemakers.

More Related Videos

Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Related Experiment Videos

Last Updated: Jul 19, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • Normal sinus node function is crucial for heart rhythm and can be impaired by aging and cardiovascular diseases.
  • Current electronic pacemakers effectively treat sinus node dysfunction but have limitations.
  • Gene therapy presents an alternative approach for developing biological pacemakers.

Purpose of the Study:

  • To review and compare different gene therapy strategies for creating biological pacemakers.
  • To evaluate the strengths and weaknesses of various gene therapy approaches.
  • To discuss the application of viral vectors in gene therapy for cardiac pacing.

Main Methods:

  • Review of existing literature on gene therapy for biological pacemakers.
  • Analysis of approaches including receptor overexpression, ion channel modulation, and stem cell modification.
  • Discussion of viral vector technologies used in these strategies.

Main Results:

  • Several gene therapy strategies have been explored, including beta(2)-adrenergic receptor overexpression, inward rectifier current downregulation, and pacemaker current overexpression.
  • Recent advances involve bioengineered ion channels and genetically modified stem cells for pacemaker function.
  • Different viral vectors are employed, each with specific advantages and disadvantages.

Conclusions:

  • Gene therapy offers a potential alternative to electronic pacemakers for treating cardiac rhythm disorders.
  • Various gene therapy approaches show promise, with ongoing research focusing on optimizing efficacy and safety.
  • Understanding the strengths, weaknesses, and vector choices is crucial for advancing biological pacemaker development.